Abstract #3958

Iron Oxide-Based T2-weighted MRI and NMR Metabolomics of Radiation and Chemotherapy Induced Inflammation in Glioma Models

Heather Caulkins¹, Paul Hong², Ksenia Serdukova³, Kendra Huber¹, Denise Davis¹, Jenna Steiner¹, and Natalie Julie Serkova¹

¹Anesthesiology, University of Colorado Denver, Aurora, CO, United States, ²Penn State Health, Hershey, PA, United States, ³University of Colorado Boulder, Boulder, CO, United States

Radio- and chemotherapy for gliomas cause a macrophage-driven inflammation called pseudoprogression (PsP) which appears as abnormal MRI enhancement mimicking treatment response. Our quantitative NMR metabolomics in murine glioma models show a significant increase in amino acid uptake and metabolism (glutamine, glycine, methionine, and tyrosine), lactate and phospholipids in actively proliferating untreated gliomas. Iron oxide is taken up uniquely by inflammatory macrophages, as shown by decreased T2-MRI contrast and an increase in the F4/80 macrophages during treatment-induced PsP. This imaging platform may provide a promising discernment of PsP (iron oxide qT2MRI) and true progression (amino acid PET) for gliomas.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.